This is Mind Cure's third high-profile addition to its Scientific Advisory Board in the last week.
Exploring the companies and themes that make up this emerging and exciting new sector
Mind Cure Welcomes Award-Winning Journalist and Science Researcher Hamilton Morris to Advisory Board
Noted psychedelic drug expert, Hamilton Morris, is the latest addition to Mind Cure's advisory board.
Mind Cure Adds 'Hamilton's Pharmacopiea' Creator As Scientific Advisor
Mind Cure adds a thought leader in the psychedelics space to its Advisory Board.
Field Trip Health Ltd. Completes Reverse Take-Over Transaction and Prepares for Listing on the Canadian Securities Exchange
Field Trip to commence trading October 7th on the CSE, symbol "FTRP".
Dr. Dan Engle Joins Mind Cure's (CSE: MCUR) Advisory Board
The world-renowned transformative medicine expert will contribute towards Mind Cure's work in the realm of psychedelic research, treatment and integration
Mind Cure (CSE: MCUR) Adds World-Renowned Psychedelic Researcher To Advisory Board
Dr. Dan Engle, a leading voice in psychedelic medicine, has been appointed by Mind Cure (CSE:MCUR) as a scientific advisor
Mind Cure (CSE: MCUR) Announces Kelsey Ramsden as new Chief Operating Officer
The company bolsters its executive team with the addition of an industry leader and experienced entrepreneur
Mind Cure Adds High-Profile Female As New COO
Mind Cure's new Chief Operating Officer has already launched several successful businesses.
Mind Cure Adds Two-Time Female Entrepreneur of The Year As New COO
Mind Cure's new Chief Operating Officer has already launched several successful businesses.
Field Trip Psychedelics Inc. Announces Successful GLP Synthesis, Results From Initial Preclinical Testing for FT-104, its First Molecule in Development
Field Trip announces testing of its first synthesized psychedelics molecule.
Will MindMed Be The Next Billion-Dollar Psychedelic Stock?
With trading volumes going through the roof and a potential NASDAQ listing, will MindMed be the next billion-dollar psychedelics company?
Mindleap Health Announces The Launch of The World’s First Telehealth Platform For Psychedelic Integration
Mydecine Innovation's Mindleap subsidary launches a telehealth platform for psychedelics.